 advanc prostat carcinoma earli versu late endocrin therapi landmark observ huggin hodg androgen depriv mainstay treatment advanced-stag prostat cancer studi enhanc surviv hormon therapi view disfavor result observ first second vacurg studi prolifer experiment clinic data earli androgen depriv reanalysi vacurg data surviv advantag patient stage diseas high-grad tumor androgen-abl therapi time diagnosi risk-benefit analysi review support earli hormon therapi long-term surviv patient metastat prostat cancer develop novel treatment strategi effect androgen-resist tumor cell use concert earli androgen depriv